Search
for
Sort by
Research 61–90 of 1000+
- The differences between aromatizable and non-aromatizable androgens in relation to body composition and metabolic syndrome risk factors in men
- Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
- Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression
- Novel Systematics of Nomenclature and Classification of Female Functional Androgenization (Including Polycystic Ovary Syndrome and Non-Classic Congenital Adrenal Hyperplasia)
- Diabetes and cardiovascular events in women with polycystic ovary syndrome: a 20-year retrospective cohort study
- PCOS in Adolescence and Type 2 Diabetes
- Insulin Promotes Corneal Nerve Repair and Wound Healing in Type 1 Diabetic Mice by Enhancing Wnt/β-Catenin Signaling
- Bioconversion, Pharmacokinetics, and Therapeutic Mechanisms of Ginsenoside Compound K and Its Analogues for Treating Metabolic Diseases
- Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan
- Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
- The Molecular Mechanism Underlying the Proliferating and Preconditioning Effect of Vitamin C on Adipose-Derived Stem Cells
- Serum lipid profile and insulin resistance in women with polycystic ovary syndrome (PCOS)
- Glycolytic Dysfunction in Granulosa Cells and Its Contribution to Metabolic Dysfunction in Polycystic Ovary Syndrome
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
- Adult polycystic ovary syndrome begins in childhood
- Metabolic syndrome in Greek women with polycystic ovary syndrome: prevalence, characteristics and associations with body mass index. A prospective controlled study
- A patient with combined polycystic ovary syndrome and autoimmune polyglandular syndrome type 2
- Metabolic risk in PCOS: phenotype and adiposity impact
- Myo-inositol in polycystic ovary syndrome: a systematic review and positioning of its use
- Polycystic Ovarian Syndrome: Long-Term Health Consequences
- Implications of a Clinically Ignored Site of Acanthosis Nigricans: The Knuckles
- Management OF Patients with Polycystic Ovary Syndrom
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
- ACOG Practice Bulletin No. 108: Polycystic Ovary Syndrome
- Mechanisms of Disease: selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 as a novel treatment for the metabolic syndrome
- Protective cardiovascular and renal actions of vitamin D and estrogen
- Definition criteria and diagnostic assessments
- Emerging Topics in Cardiometabolic and Psychologic Sequelae, Pathogenesis, and Treatment of Polycystic Ovarian Syndrome: A Review
- Dermatologic manifestations of endocrine disorders
- Comorbidities in alopecia areata: A systematic review and meta-analysis